Risk factors for persistent airflow limitation: Analysis of 306 patients with asthma. 2014

Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
Lingcheng Wang, MD, Department of Respiratory Medicine, Fourth People's Hospital of Jinan City, Shandong Province, 250031, China.

Objectives : To determine the risk factors associated with persistent airflow limitation in patients with asthma. Method s: This study was designed and carried out in the department of respiratory medicine, fourth People's Hospital of Jinan City, Shandong province, China between Jan 2012 and Dec 2012. Three hundred and six asthma patients participating in the study were divided into persistent airflow limitation group (PAFL) and no persistent airflow limitation group (NPAFL). The patients participated in pulmonary function tests and sputum induction examination. The clinical data including age, gender, onset age, disease course, smoking history, family history, regular corticosteroid inhalation, hospitalization history and presence of atopy were collected. Results : In 306 patients, 128 (40.5%) were included in PAFL group and 178(59.5%) in NPAFL group. Multivariate analysis demonstrated smoking (≥10 pack-years; OR, 7.1; 95% CI, 1.8 to 31.2), longer asthma duration (≥ 20years) (OR, 6.3; 95% CI, 1.7 to 28.5), absence of regular corticosteroid inhalation (OR, 3.5; 95% CI, 1.1 to 14.5) and neutrophil in induced sputum≥65% (OR, 1.8; 95% CI, 1.0 to 2.8) were independent risk factors for PAFL. Conclusions : Smoking, longer asthma duration and increased neutrophil in induced sputum are risk factors for PAFL, while regular corticosteroid inhalation is protective factor. Smoking cessation and regular corticosteroid inhalation may play an important role in preventing the occurrence of persistent airflow limitation group (PAFL).

UI MeSH Term Description Entries

Related Publications

Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
September 2001, American journal of respiratory and critical care medicine,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
February 2008, Current opinion in allergy and clinical immunology,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
November 2022, The Lancet. Respiratory medicine,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
September 2020, The European respiratory journal,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
November 2022, The Lancet. Respiratory medicine,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
September 2017, The European respiratory journal,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
July 2016, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
May 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Lingcheng Wang, and Shuncui Gao, and Wei Zhu, and Jun Su
September 2013, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Copied contents to your clipboard!